![HealthTree Podcast for Multiple Myeloma artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts113/v4/8f/ab/bd/8fabbdcd-0da0-0239-dac5-df547f82810a/mza_6724809222047263023.jpg/100x100bb.jpg)
Multiple myeloma mid-year progress with Dr. Paul Richardson of Dana Farber
HealthTree Podcast for Multiple Myeloma
English - September 22, 2023 18:00 - 1 hour - 29.2 MB - ★★★★★ - 13 ratingsHealth & Fitness myeloma multiple myeloma Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Stem Cell Transplant Advances and Use in the Age of Immunotherapy
Dr. Paul Richardson of the Dana Farber Cancer Institute shares a mid-year myeloma review of ASCO, EHA and upcoming International Myeloma Society findings of the fast-moving research being performed in myeloma. Updates will include the expanding world of bispecific antibodies that include one FDA-approved drug and anticipated approvals for two new bispecific antibodies. He will also discuss exciting results from CAR T cinical trials, CAR T newcomers, sequencing preferences, BCMA targeted therapies, new therapy targets in myeloma, MRD advances, blood-based testing, clinical trials end points and more.
Thanks to our episode sponsor, Karyopharm.